CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company
Next Investors
Mar 15, 2021
Creso Pharma (ASX: CPH) will be the first ASX listed stock to acquire 100% of a psychedelics company. CPH is set to acquire Canada based Halucenex Life Sciences Inc., an established psychedelics company developing treatments for a range of mental illnesses.
